Related references
Note: Only part of the references are listed.Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial
Young-Suk Lim et al.
GUT (2016)
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial
Young-Suk Lim et al.
GUT (2016)
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis
Robert S. Brown et al.
HEPATOLOGY (2016)
Randomized, Controlled Trial of Entecavir Versus Placebo in Children With Hepatitis B Envelope Antigen-Positive Chronic Hepatitis B
Maureen M. Jonas et al.
HEPATOLOGY (2016)
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
Anna S. F. Lok et al.
HEPATOLOGY (2016)
Tenofovir versus Entecavir in Treatment of Chronic Hepatitis B Virus with Severe Acute Exacerbation
Chao-Hung Hung et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Clinical Events After Cessation of Lamivudine Therapy in Patients Recovered From Hepatitis B Flare With Hepatic Decompensation
Ming-Ling Chang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Effect of Nucleoside and Nucleotide Analogues on Renal Function in Patients With Chronic Hepatitis B Virus Monoinfection
Vincent Mallet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy
George K. Siberry et al.
CLINICAL INFECTIOUS DISEASES (2015)
Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects
Grace Lai-Hung Wong et al.
HEPATOLOGY (2015)
Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis
Jeong Won Jang et al.
HEPATOLOGY (2015)
Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis
William Kemp et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
Gi-Ae Kim et al.
JOURNAL OF HEPATOLOGY (2015)
Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials
Xiaojie Huang et al.
SCIENTIFIC REPORTS (2015)
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
Maria Buti et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Long-Term Treatment with Tenofovir in Asian-American Chronic Hepatitis B Patients Is Associated with Abnormal Renal Phosphate Handling
Connie Tien et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Mo1833 Efficacy and Safety of Entecavir Versus Tenofovir Treatment in Chronic Hepatitis B Patients: A Randomized Controlled Trial
Tassanee Sriprayoon et al.
GASTROENTEROLOGY (2015)
Effect of Virological Response to Entecavir on the Development of Hepatocellular Carcinoma in Hepatitis B Viral Cirrhotic Patients: Comparison Between Compensated and Decompensated Cirrhosis
Soon Sun Kim et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Screening for Hepatitis B Virus Infection in Adolescents and Adults: A Systematic Review to Update the US Preventive Services Task Force Recommendation
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2014)
Prevention of Vertical Transmission of Hepatitis B An Observational Study
Ai Kubo et al.
ANNALS OF INTERNAL MEDICINE (2014)
Efficacy of Entecavir-Tenofovir Combination Therapy for Chronic Hepatitis B Patients with Multidrug-Resistant Strains
Yun Bin Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study
Amanda H. Corbett et al.
ANTIVIRAL THERAPY (2014)
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B
W. -K. Seto et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B
Scott Fung et al.
GASTROENTEROLOGY (2014)
Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naive patients with chronic hepatitis B: a multicenter real-life study
Ayse Batirel et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Pharmacokinetics and Safety of Tenofovir in HIV-Infected Women During Labor and Their Infants During the First Week of Life
Mark Mirochnick et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients
Thomas Berg et al.
JOURNAL OF HEPATOLOGY (2014)
Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B
G. L. -H. Wong et al.
JOURNAL OF VIRAL HEPATITIS (2014)
HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?
Mauro Vigano et al.
LIVER INTERNATIONAL (2014)
Long-term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of Hepatitis B Virus-Related Cirrhosis
Seyfettin Koklu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
Danny Ka-Ho Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Association Between Tenofovir Exposure and Reduced Kidney Function in a Cohort of HIV-Positive Patients: Results From 10 Years of Follow-up
Claudie Laprise et al.
CLINICAL INFECTIOUS DISEASES (2013)
Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice
Anne Liu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Off-Therapy Durability of Response to Entecavir Therapy in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients
Wen-Juei Jeng et al.
HEPATOLOGY (2013)
Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010
Rania A. Tohme et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice
R. Salpini et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis
Xiao-Guang Ye et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus
Yali Hu et al.
BMC PREGNANCY AND CHILDBIRTH (2013)
Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B
Robert G. Gish et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naive Patients With Chronic Hepatitis B
Anna S. Lok et al.
GASTROENTEROLOGY (2012)
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
Tai-Chung Tseng et al.
GASTROENTEROLOGY (2012)
Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2012)
Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin
Kris V. Kowdley et al.
HEPATOLOGY (2012)
High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy
Kevin T. Chaung et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers
H. Zou et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis
Young Eun Chon et al.
PLOS ONE (2012)
Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B
Umit Bilge Dogan et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2012)
A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women
Kui-Xia Sun et al.
VACCINE (2012)
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
J. J. Ott et al.
VACCINE (2012)
Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation
M. Vigano et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence
Andrew M. Hall et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Hepatitis B Virus in the United States: Infection, Exposure, and Immunity Rates in a Nationally Representative Survey
George N. Ioannou
ANNALS OF INTERNAL MEDICINE (2011)
Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2
Sihem Benaboud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B
Eugene R. Schiff et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Entecavir Treatment for Chronic Hepatitis B: Adaptation Is Not Needed for the Majority of Naive Patients with a Partial Virological Response
Roeland Zoutendijk et al.
HEPATOLOGY (2011)
Efficacy and Safety of Entecavir Versus Adefovir in Chronic Hepatitis B Patients With Hepatic Decompensation: A Randomized, Open-Label Study
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Shorter Durations and Lower Doses of Peginterferon alfa-2a Are Associated with Inferior Hepatitis B e Antigen Seroconversion Rates in Hepatitis B Virus Genotypes B or C
Y. -F. Liaw et al.
HEPATOLOGY (2011)
Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients
Feng Liu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B
Stefan Mauss et al.
JOURNAL OF HEPATOLOGY (2011)
A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus
Lei Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Systematic Review and Meta-analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV-Infected Patients
Ryan D. Cooper et al.
CLINICAL INFECTIOUS DISEASES (2010)
SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease
Jeffrey B. Schwimmer et al.
GASTROENTEROLOGY (2010)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options
Maureen M. Jonas et al.
HEPATOLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Virological, serological and biochemical outcomes through 3 years of entecavir treatment in nucleoside-naive Chinese chronic hepatitis B patients
G. B. Yao et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Incidence and Risk Factors of Progression to Cirrhosis in Inactive Carriers of Hepatitis B Virus
Chia-Ming Chu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Antiretroviral Concentrations in Breast-Feeding Infants of Mothers Receiving Highly Active Antiretroviral Therapy
Mark Mirochnick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Tenofovir Disoproxil Fumarate In Chronic Hepatitis B
Caroline M. Perry et al.
DRUGS (2009)
Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2009)
Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
Patrick Marcellin et al.
GASTROENTEROLOGY (2009)
Side Effects of Long-Term Oral Antiviral Therapy for Hepatitis B
Robert J. Fontana
HEPATOLOGY (2009)
Severe Lactic Acidosis During Treatment of Chronic Hepatitis B with Entecavir in Patients with Impaired Liver Function
Christian M. Lange et al.
HEPATOLOGY (2009)
The Natural History of Chronic Hepatitis B Virus Infection
Brian J. McMahon
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B
Yun-Fan Liaw
HEPATOLOGY INTERNATIONAL (2009)
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The clinical significance of persistently normal ALT in chronic hepatitis B infection
Michelle Lai et al.
JOURNAL OF HEPATOLOGY (2007)
Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B
Robert G. Gish et al.
GASTROENTEROLOGY (2007)
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
Chee-Kin Hui et al.
HEPATOLOGY (2007)
Chronic hepatitis B virus carriers in the immunotolerant phase of infection:: Histologic findings and outcome
Tony Andreani et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
Shi-Ming Lin et al.
JOURNAL OF HEPATOLOGY (2007)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005
HJ Yim et al.
HEPATOLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Natural history of chronic HBV infection: A cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project)
GH Zacharakis et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment
RL Shapiro et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy
MJ Parsonage et al.
HIV MEDICINE (2005)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
SJ Hadziyannis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Long-term results of lamivudine monotherapy in Korean patients with HBeAg-positive chronic hepatitis B: Response and relapse rates, and factors related to durability of HBeAg seroconversion
SK Yoon et al.
INTERVIROLOGY (2005)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised
HLA Janssen et al.
LANCET (2005)
Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy
J Summers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B
SK Fung et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
CM Chu et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B
D Thabut et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection
S Manolakopoulos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Seropositivity of hepatitis B e antigen and hepatocellular carcinoma
SL You et al.
ANNALS OF MEDICINE (2004)
Determinants for sustained HBeAg response to lamivudine therapy
RN Chien et al.
HEPATOLOGY (2003)
Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan
YH Huang et al.
JOURNAL OF VIRAL HEPATITIS (2003)
Natural history and prognosis of hepatitis B
G Fattovich
SEMINARS IN LIVER DISEASE (2003)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati et al.
ANNALS OF INTERNAL MEDICINE (2002)
Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease
GV Papatheodoridis et al.
HEPATOLOGY (2002)
Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
T Santantonio et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
